Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents Nexgel, Inc. (NXGL): Beauty Harnessed From Water

CEO Adam Levy educates us on the use of energy from their electron beam accelerator to crosslink water and polymers into beautifying sheets of water.

Biotechnology
June 17, 2022

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: BioHarvest Sciences (BHST) – Global Leader in Plant Cell Technology December 03, 2024
Sequire Spotlight Presents: Biostem (BSEM) – Harnessing the Natural Properties of Placenta Tissues November 20, 2024
Sequire Spotlight Presents IGC Pharma (IGC): A Focus on Alzheimer’s Molecules August 22, 2023
Sequire Spotlight Presents Equillium Inc (EQ): Leaders in the Field of Immunobiology August 22, 2023
Sequire Spotlight Presents PetVivo Holdings, Inc. (PETV): Adapting Human Biotech Into The Veterinary Industry. November 09, 2022
Sequire Spotlight Presents Lexaria Bioscience (LEXX): Bringing Vitamin Delivery to the Next Level September 19, 2022
Sequire Spotlight Presents Chromadex (CDXC): Unleashing the Guarded Secret to Better Aging June 17, 2022
Sequire Spotlight Presents Aclarion Inc (ACON): The Future of Medical Imaging Technology October 26, 2023
Sequire Spotlight Presents Cytta Corp. (CYCA): The Masters of Designing Video and Audio Technology June 17, 2022
Sequire Spotlight Presents RYVYL Inc. (RVYL): GREENBOX POS Changes Name To RYVYL INC. December 27, 2022

Related Post

Pacaso — The $1.3 Trillion Secret That Everyday Investors Are Finally Invited To

May 6, 2025
OS Therapies FDA Meeting Request Granted

April 22, 2025
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans

April 10, 2025
OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline

January 29, 2025

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.